ConductScience.org, home

Gene · 1213

NIH grants2,119

NIH grants whose papers are about the gene, through NIH's grant-paper links.

681 to 700 of 2,119

Download this page as JSON
GrantTitleCLTC papersNewest fiscal year
P41GM103712High Performance Computing for Multiscale Modeling of Biological Systems12021
P41GM104601Center for Macromolecular Modeling and Bioinformatics12021
P50CA211024Weill Cornell Medicine (WCM) SPORE in Prostate Cancer12021
R01AG018440a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease12021
R01AG027924ApoE pathway in cerebrovascular Aβ clearance in Alzheimer's disease12021
R01AG055948Dietary Quality, Cognitive Decline and Brain Health in Puerto Rican Adults12021
R01AI080672REGULATION OF HOST RESPONSES TO RESPIRATORY VIRAL INFECTION BY ISG1512021
R01AI103083Membrane Hijacking: Biogenesis and Fate of Quasi-Enveloped Hepatovirus12021
R01AI123144Identification of Host and Viral Determinants of Human Norovirus B cell Infection12021
R01AI125579Identification and validation of molecular markers of piperaquine resistance12021
R01AI131685Murine Model of Human Hepatitis A12021
R01AI132633Dissecting the receptor-mediated infection mechanisms of hantaviruses12021
R01AI140736ST6Gal-1 Sialyltransferase in Inflammation12021
R01AR055686Understanding the mechanism and role of cell membrane repair in Miyoshi Myopathy12021
R01AR061370NADPH Oxidase and Autophagic Dysfunction in Duchenne Muscular Dystrophy12021
R01CA092900Role of HOS in Cell Transformation and Apoptosis12021
R01CA100670DNA Cross-Linking By Diepoxybutane12021
R01CA120528Prospective Validation of Prognostic and Predictive Molecular tests in Mesothelioma12021
R01CA162804Pathway Choice of DNA Double-Strand Break Repair12021
R01CA206069Development of Targeted Nanotechnology Platform for Pancreatic Cancer12021

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1213/grants?page=35